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Abstract: Ethyl oleate (1) reacts with hydrazine hydrate to form stearic acid hydrazide (2), the reaction
proceeds with the simultaneous reduction of  9,10 C=C bond of ethyl oleate. The stearic acid hydrazide formed
on intermolecular cyclisation with different aliphatic acids, aromatic acids (3), or ethyl oleate (1) in the presence
of phosphorus oxychloride forms 2,5-disubstituted 1,3,4-oxadiazoles (4) in good yield. The structure proofs of
the product were confirmed by spectral studies and elemental analysis.
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Introduction
Human body requires fats to function properly; fatty acids serve as the components of more complex membrane
lipids and as major components of stored fat in the body. Chemically, fatty acids and their esters are used in the
synthesis of oxazoles, the utility of these adducts for structural investigations of natural and artificial fatty acids
are now well established1. Oxazolines of highly unsaturated fatty acids were used to determine the double bond
position by mass spectrometry2. Heterocyclic compounds particularly nitrogen heterocycles they have been
successfully tested against several diseases and therefore received special attention in pharmaceutical chemistry
due to their diverse medicinal potential. Among the heterocycles; five-member heterocycles such as 1,3,4-
oxadiazoles continuously draws interest for development of newer drug moiety3-5. They have demonstrated a
broad spectrum of biological properties in both pharmaceutical and agrochemical fields. Substituted 1,3,4-
oxadiazole derivatives have known to exhibit enormous biological activities such as CNS depressant6, anti-
inflammatory activity7, as anticonvulsant, herbicidal and HIV properties3. They also show a remarkable
analgesic, anti-convulsant, diuretic, hypnotic and sedative properties8.
Symmetric and unsymmetric 1,3,4-oxadiazoles were synthesized in situ from hydrazine hydrate and the
corresponding 2-acyl-4,5-dichloropyridazin-3-ones as acylating agents in PPA9. 2,5-Disubstituted 1,3,4-
oxadiazoles synthesized by cyclisation of 3-aroylpropionic acid hydrazides in the presence of phosphorous
oxychloride showed anti-inflammatory and analgesic effects with reduced gastric irritation10. 2-Chloro-bis-
1,3,4-oxadiazoles were synthesized by the reaction of 2-chloro-1.4-phenylene-dioxybis-acetyl hydrazine with
aromatic carboxylic acids in the presence of phosphorous oxychloride11. Fatty acid hydrazides are used as cheap
starting materials in the synthesis of important biologically active 1,3,4-oxadiazoles using cyanogen bromide
and benzoyl chloride or benzoic acid as reagents respectively12. Oxadiazoles synthesized via 1,3-dipolar
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cycloaddition of nitrile oxides with imines showed promising antifungal and antibacterial activity13. Prompted
by the varied applications of 1,3,4-oxadiazoles, the present study has been undertaken with a hope of getting
more biologically potent molecules.
Experimental
The reagents and chemicals used were of analytical grade and were purchased from sigma-aldrich chemicals
(India), and Merck Chemicals (India) Ltd. Melting points were determined using open capillary tube method
and are uncorrected. Thin layer chromatography (TLC) was performed on a pre-coated Silica Gel sheets (HF
254, sd-fine) to monitor the reactions and purity of the compounds. n-Hexane:ethyl acetate (7:1) were used as
eluent, visualization of the spots was done in iodine vapour and UV light. Chromatographic separations were
carried carried out on silica gel (70-230 mesh, Merck) column using n-hexane:ethyl acetate (7:1)as eluent. IR
spectra were recorded using KBr disk on a Shimadzu Perkin-Elmer 8201 FTIR. The 1H NMR and 13C NMR
spectra were recorded on Bruker 500MHz spectrophotometer in CDCl3 using TMS as internal reference. The
Chemical shifts are expressed in δ ppm. The mass spectra (LCMS) were obtained on a Shimadzu LCMS-2010A
spectrophotometer as APCI-POS1. Elemental analysis was obtained on a Thermo Finnigan Flash EA 1112 CHN
analyser.
Synthesis of stearic acid hydrazide (2)14: A mixture of ethyl oleate (0.01 mol) and hydrazine hydrate (0.01
mol) in absolute alcohol (30ml) was refluxed on a water bath for 3 hrs. After the completion of the reaction, the
solvent was removed to dryness; the residue was poured into ice cold water with stirring. The mass obtained
was filtered, washed with water and recrystallised from ethanol. After purification the stearic acid hydrazide
obtained in 82% yield, m.p. 114-1160C (Scheme 1).
General procedure for the synthesis of 1,3,4-oxadiazoles (4): A mixture of hydrazide (0.01mol), suitable
aliphatic or aromatic acids or ethyl oleate (0.01mol) and phosphorous oxychloride (0.03 mol) were refluxed on
water bath for 4-5 hrs. Then the reaction mixture was cooled to room temperature and poured into ice cold
water, and was neutralized with sodium bicarbonate solution. The resulting solid was filtered, dried and
crystallized from 80% ethyl alcohol (Scheme 1).
Results And Discussion
2-(Chloromethyl)-5-heptadecyl-1, 3, 4-oxadiazole (4a): Obtained from stearic acid hydrazide 2 and
chloroacetic acid 3a in 64% yield, m.p. 56-58˚C. IR (KBr, γ cm-1): 3087 (C-H str), 1619 (C=N str), 1251(N-
N=C str), 1090 (C-O-C str). 1H NMR (CDCl3):  0.94 (3H,t,CH3), 1.27 (26H,m, (CH2) 13), 1.34 (2H,m,CH2),1.62
(2H,m,CH2 β to ring), 2.58 ( 2H,t,J = 7.5 Hz, CH2 α  to ring),4.63 (2H,CH2, α to Cl atom). 13C NMR (CDCl3): 
14.6 (1C, CH3), 23.0 (1C, CH2), 27.3 (2C, CH2), 29.8 (3C, CH2), 30.1 (1C, CH2), 30.9 (3C, CH2), 31.4 (4C,
CH2), 32.4 (1C, CH2), 33.5 (1C, CH2), 36.6 (1C, CH2), 45.2 (1C, CH2),  159.2 (1C, C-5), 164.6 (1C, C-2).
Anal.Cald.for C20H37ClN2O: C, 67.29, H, 10.45, N, 7.85; Found: C, 67.30, H, 10.47, N, 7.86%.
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2-Benzyl-5-heptadecyl-1,3,4-oxadiazole (4b): Obtained from stearic acid hydrazide 2 and phenylacetic acid 3b
in 48% yield, m.p. 68-70˚C. IR (KBr, γ cm-1): 3055 (C-H str), 1620 (C=N str), 1422 (C=C str), 1251(N-N=C
str), 1082 (C-O-C str). 1H NMR (CDCl3):  0.96 (3H,t,CH3),1.27 (26H,m, (CH2) 13), 1.34 (2H,m,CH3),1.69
(2H,m,CH2 β to ring), 2.56 ( 2H,t,J = 7.5 Hz, CH2 α  to ring), 3.82 (2H, CH2, α to ring), 7.05-7.15 (5H, m, Ar-
H). 13C NMR (CDCl3):  14.1 (1C, CH3), 23.1 (1C, CH2), 27.3 (2C, CH2), 29.5 (1C, CH2), 30.1 (1C, CH2), 30.4
(3C, CH2), 30.9 (4C, CH2), 32.4 (1C, CH2), 33.7 (1C, CH2), 36.2 (1C, CH2), 125.4 (1C, C6H5-C), 128.6 (2C,
C6H5-C), 127.2 (2C, C6H5-C), 129.8 (2C, CH2), 137.2 (1C, C6H5-C), 157.2 (1C, C-5), 163.9 (1C, C-2). MS
(relative abundance) m/z: 399 (MH+, 100), 371 (10), 308 (16), 160 (14). Anal.Cald.for C26H42N2O: C, 78.34, H,
10.62, N, 7.03; Found: C, 78.36, H, 10.47, N, 7.15%.
2-Heptadecyl-5-phenyl-1,3,4-oxadiazole (4c): Obtained from stearic acid hydrazide 2 and benzoic acid 3c in
63% yield, m.p. 83-85˚C. IR (KBr, γ cm-1): 3054 (C-H str), 1620 (C=N str), 1420 (C=C str), 1252(N-N=C str),
1084 (C-O-C str). 1H NMR (CDCl3):  0.91 (3H,t,CH3), 1.26 (26H,m, (CH2)13),1.34( 2H,m, CH2), 1.66
(2H,m,CH2 β to ring), 2.52 ( 2H,t,J = 7.5 Hz, CH2 α  to ring),7.20- 7.7.48 (5H, m, Ar-H). 13C NMR (CDCl3): 
14.2 ( 1C, CH3), 22.5 (1C, CH2), 29.3 (2C, CH2), 29.6 ( 10C, CH2), 31.4 (2C, CH2), 32.6 (1C, CH2), 126.2 (1C,
Ar-C), 127.3 (2C, Ar-C), 129.5 (2C, Ar-C), 128.7 (1C, Ar-C), 152.2 (1C, 5-C  ), 164.2 (1C, 2-C). Anal.Cald.
for C25H40N2O: C,78.07, H, 10.48, N, 7.28; Found: C, 78.02, H, 10.46, N, 7.26%.
2-Heptadecyl-5-styryl-1,3,4-oxadiazole (4d): Obtained from stearic acid hydrazide 2 and cinnamic acid 3d in
62% yield, m.p. 60-62˚C. IR (KBr, γ cm-1): 3050 (C-H str), 1622 (C=N str), 1422 (C=C str, 1256(N-N=C str),
1080 (C-O-C str). 1H NMR (CDCl3):  0.97 (3H,t,CH3), 1.28 (26H,m,(CH2)13), 1.32 (2H,m,CH2),1.67
(2H,m,CH2 β to ring), 2.55 ( 2H,t,J = 7.5 Hz, CH2 α  to ring),6.50 (2H, d , CH=CH, α to ring), 7.15-7.29 (5H, m,
Ar-H). 13C NMR CDCl3: δ 13.8 (1C, CH3), 23.2 (1C, CH2), 27.0 (2C, CH2), 29.5 (1C, CH2), 30.3 (1C, CH2),
30.7 (3C, CH2), 30.9 (4C, CH2), 32.5 (1C, CH2), 33.9 (1C, CH2), 124.3 (1C, CH=C), 126.6 (2C, C6H5-C), 127.4
(1C, C6H5-C), 128.2 (2C, C6H5-C), 130.2 (1C, CH=C), 132.38 (2C, CH2), 135.2 (1C, C6H5-C), 157.1 (1C, C-5),
163.2 (1C, C-2). MS (relative abundance) m/z: 411(MH+, 100), 383 (12), 334 (08), 308 (22), 172 (18).
Anal.Cald.for C27H42N2O: C, 78.97, H, 10.31, N, 6.82; Found: C, 78.88, H, 10.27, N, 6.71%.
5-Heptadecyl-2-(2-hydroxyphenyl)-1,3,4-oxadiazole (4e): Obtained from stearic acid hydrazide 2 and salicylic
acid 3e in 55% yield, m.p. 90-92˚C. IR (KBr, γ cm-1): 3454 (phenolic –OH str), 3052 (C-H str),salicylic acid 3e
in 55% yield, m.p. 90-92˚ C. IR (KBr, γ cm-1): 3454 (phenolic –OH str),3052 (C-H str), 1619 (C=N str), 1424
(C=C str), 1252(N-N=C str), 1091 (C-O-C str). 1H NMR (CDCl3):  0.95 (3H,t,CH3),1.27 (26H,m, (CH2) 13),
1.30 (2H,m,CH2),1.60 (2H,m,CH2 β to ring), 2.56 ( 2H,t,J = 7.5 Hz, CH2 α  to ring), 5.00 (1H, s, OH, ), 6.80
(2H, dd, Ar-H), 7.32 (2H, dd, Ar-H). 13C NMR (CDCl3):  14.3 ( 1C, CH3), 22.7 (1C, CH2), 29.4 (1C, CH2),
29.8 ( 10C, CH2), 31.3 (1C, CH2), 31.8 (1C, CH2), 32.7 (1C, CH2), 112.2(1C, Ar-C), 116.6 (1C, Ar-C), 121.8
(1C, Ar-C), 128.8 (1C, Ar-C), 130.3 ((1C, Ar-C), 152.3 (1C, 5-C), 155.4 (1C,Ar-C), 164.3 (1C, 2-C),
Anal.Cald.for C25H40N2O2: C, 74.95, H, 10.06, N, 6.99; Found: C, 74.98, H, 10.46, N, 6.85%.
2-Heptadecyl-5-(2-methylphenyl)-1,3,4-oxadiazole (4f): Obtained from stearic acid hydrazide 2 and 2-methyl
benzoic acid 3f in 54% yield, m.p. 48-50˚C. IR (KBr, γ cm-1): 3052 (C-H str), 1605 (C=N Str),(C=C str,
1243(N-N=C str), 1087 (C-O-C str). 1H NMR (CDCl3):  0.98 (3H,t,CH3), 1.27 (26H,m,(CH2) 13),1.38
(2H,m,CH2),1.64 (2H,m,CH2 β to ring), 2.35(3H,s,CH3) 2.53 ( 2H,t,J = 7.5 Hz, CH2 α  to ring), 7.10-7.28 (4H,
m, Ar-H). 13C NMR (CDCl3):  14.2 ( 1C, CH3), 17.8 (1C, CH3), 22.8 (1C, CH2), 29.8 ( 10C, CH2), 29.2 (1C,
CH2), 31.1 (1C, CH2), 31.7 (1C, CH2), 32.8 (1C, CH2), 126.4 (1C, Ar-C), 127.5 (1C, Ar-C), 129.6 (1C, Ar-C),
128.6.3 ((1C, Ar-C), 136.7 (1C, Ar-C), 137.3 (1C,Ar-C), 152.0 (1C, 5-C), 164.4 (1C, 2-C). MS (relative
abundance) m/z: 399(MH+, 100), 370 (16), 308 (20), 160 (24). Anal.Cald.for C26H42N2O:C, 78.34, H, 10.62, N,
7.03; Found: C, 78.98, H, 10.46, N, 7.10%.
2-Heptadecyl-5-(4-nitrophenyl)-1,3,4-oxadiazole (3g): Obtained from stearic acid hydrazide 2 and 4-nitro
benzoic acid 3g in 69% yield, m.p. 97-99˚ C. IR (KBr, γ cm-1): 3051 (C-H str), 1642 (C=N str),1410 (C=C str),
1552,1342 (NO2 str) 1284(N-N=C str), 1083 (C-O-C str). 1H NMR (CDCl3):  0.92 (3H,t,CH3), 1.24(26H,m,
(CH2) 13),1.30 (2H,m,CH2),1.68 (2H,m,CH2 β to ring), 2.50(2H,t,J = 7.5 Hz, CH2 α to ring), 7.75 (2H, dd, Ar-H),
8.25 (2H, dd, Ar-H). 13C NMR (CDCl3):  14.0 ( 1C, CH3), 22.7 (1C, CH2), 29.5 (1C, CH2), 29.9 (10C, CH2),
31.2 (1C, CH2), 31.9 (1C, CH2), 32.9 (1C, CH2), 121.5 (2C, Ar-C), 128.6 (2C, Ar-C), 132.3 (1C, Ar-C), 148.6
(1C, Ar-C), 152.4 (1C, 5-C), 164.6 (1C, 2-C). Anal.Cald.for C25H39N3O3:C, 69.90, H, 9.15, N, 9.78; Found: C,
70.00, H, 9.20, N, 9.80%.
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2-(4-Aminophenyl)-5-Heptadecyl-1,3,4-oxadiazole (3h): Obtained from stearic acid hydrazide 2 and 4-amino
benzoic acid 3h in 70% yield, m.p. 132-134˚C. IR (KBr, γcm-1): 3049 (C-H str), 3320 (NH2 614 (C=N Str), 1467
(C=C str, 1249(N-N=C str), 1098 (C-O-C str). 1H NMR (CDCl3):  0.94 (3H,t,CH3), 1.27 (26H,m,(CH2) 13),1.34
(2H,m,CH2),1.67 (2H,m,CH2 β to ring), 2.58 ( 2H,t,J = 7.5 Hz, CH2 α  to ring), 3.98 (2H, s, NH2), 6.52 (2H, dd,
Ar-H), 7.24 (2H, dd, Ar-H). 13C NMR (CDCl3):  14.2 ( 1C, CH3), 22.7 (1C, CH2), 29.4 (1C, CH2), 29.8 ( 10C,
CH2), 31.6 (2C, CH2), 32.6 (1C, CH2), 116.4 (1C, Ar-C), 116.9 (2C, Ar-C), 128.4 (2C, Ar-C), 148.7 (1C, Ar-C),
152.5 (1C, 5-C), 164.7 (1C, 2-C). Anal.Cald.for C25H41N3O: C, 75.14, H, 10.34, N, 10.52; Found: C, 75.08, H,
10.31, N, 10.45%.
2-(Heptadec-8-enyl)-5-heptadecyl-1,3,4-oxadiazole (4i): Obtained from stearic acid hydrazide 2 and ethyl
oleate 1 in 56% yield, m.p. 112-114˚C. IR (KBr, γcm-1): 3049 (C-H str), 1614 (C=N str), 1467 (C=C str), 1249
(N-N=C str), 1098 (C-O-C str). 1H NMR (CDCl3): δ 0.90 (t, 6H, CH3), 1.30 (m, 42H, m,  (CH2)18), 1.32 (s, 6H,
CH2), 1.36 (m, 4H, CH2 β to ring), 2.06-2.19 (m, 4H, =C-CH2), 2.82 (t, 4H, J=8.0 Hz, CH2 α to ring), 5.30 (m,
2H, -CH=CH-). 13C NMR CDCl3: δ 14.1 (2C, CH3), 23.2 (2C, CH2), 23.7 (4C, CH2), 27.6 (4C, CH2), 29.2 (2C,
CH2), 30.0 (2C, CH2), 30.6 (4C, CH2), 31.5 (6C, CH2), 32.6 (2C, CH2), 33.3 (2C, CH2),  131.8 (2C, =CH), 157.7
(2C, C-5), 163.5 (2C, C-2). MS (relative abundance) m/z: 545 (MH+, 100), 517 (14), 432 (28), 406 (22), 308
(12), 306 (30). Anal.Cald.for C36H68N2O: C, 79.35, H, 12.58, N, 5.14; Found: C, 79.24, H, 12.28, N, 5.09%.
The structures proof of the products was provided by IR, 1H NMR, 13C NMR, MS studies and elemental
analysis. For instance in IR Spectra, the stretching absorption bands due to C=N appeared in the region 1610-
1620 cm-1, due to N-N=C in the region 1240-1260 cm-1 and due to C-O-C in the region 1090-1100 cm-1. In 1H
NMR spectra, the signals expected due to –CH=CH- (9, 10 positions) protons of the starting material ethyl
oleate in the region δ 5.00-6.00 ppm were found absent. Though there is a report that during the hydrazide
formation of ethyl oleate with hydrazine hydrate that the –CH=CH- bond is unaffected12. On contrary to this, the
synthesized compounds showed the spectrum corresponding –CH2-CH2- (9, 10 positions) protons. This suggests
that, during hydrazide formation with hydrazine, the 9,10 double bond of ethyl oleate underwent reduction. This
was further supported by MS studies, the mass spectrum of the compounds showed the mass peak (M+1)
corresponding to molecular weight of the reduced form of ethyl oleate as side chain in the products. The
formation of the products with reduced double bond of ethyl oleate moiety was supported the literature14. In
addition to this, all the compounds gave the signals due to aromatic protons and substituent protons at the
expected region.
In 13C NMR spectra, the signals due to C2-carbon appear in the region δ 161.0-164.0 ppm., the signals
due to C5-carbon appear in the region δ 151.0-154.0 ppm. All showed the signals due to aromatic carbons and
substituent carbons in the expected region. All the cycloadducts gave significantly stable molecular ion peaks
with a relative abundance ranging from 08-30% and base peak at (M+1). Further, all showed satisfactorily
elemental analysis with a deviation of ± 0.02% from the theoretically calculated values. These observations
strongly favor the formation of the products 4a-i.
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